Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...

"Most men see us as their mother, not the co-parent in the home. We parent, they babysit. There's an unattainably high bar ...

Ride-hailing service Bolt says it is making rides safer and more comfortable for women with a new feature allowing female passengers to prioritise female drivers. This initiative also supports women ...

A new approach that used CRISPR to engineer adipocytes and implant them in mice models of cancer reduced cancer progression.

Glutathione, known as the 'master antioxidant', is praised for its benefits including detoxification, boosting immunity, ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

The health care community has redefined the requirements for clinical obesity, noting BMI shouldn’t be the sole barometer of ...

We typically think of menopause as something that impacts women in their 50s, but it’s good to know what’s coming down the ...

FRANKFORT, Ky. (WBKO) - Seven innovative Kentucky companies will receive $749,964 in state matching grants to support ...